OBJECTIVES:
To describe the anatomic and symptomatic outcomes of women treated with abdominal sacrohysteropexy (ASH).
MATERIALS AND METHODS:
We performed a retrospective chart review with prospective physical examination and quality of life measures for women who have undergone ASH. The ASH was performed at a single institution by a board certified Urogynecologist. All patients had a piece of hand tailored Gynemesh affixed to the posterior vaginal wall and sacral promontory. Women who had completed childbearing had a second piece of Gynemesh affixed to the anterior vaginal wall, passed through a window created in the broad ligament, and affixed to the sacral promontory. For women who were uncertain or desired future childbearing, the anterior dissection was not performed. Postoperative pelvic examinations were performed by a Urogynecology fellow independently of the surgeon who performed the surgical procedures, including supine POP-Q and standing examinations. Quality of life was assessed with the Incontinence Impact Questionnaire-7 (IIQ-7), the Pelvic Organ Prolapse/Urinary Incontinence Sexual Function Questionnaire (PISQ-12), and Pelvic Floor Distress Inventory-Short Form 20 . RESULTS: Sixteen patients underwent ASH between 2006 and 2012 and met inclusion criteria. Thirteen women (81.3%) were available for follow-up. At baseline, all patients had a presenting complaint of pelvic organ prolapse, 6 reported stress urinary incontinence, and 2 reported mixed urinary incontinence. At initial presentation, mean (standard deviation [SD]) BMI was 26.6 (5.7). The number of patients in prolapse stages were: apical stage 0-I: 1, apical II-III: 12; anterior 0-I: 2, anterior II-III: 11; posterior 0-I: 2, posterior II-III: 11. Mean (SD) operating time was 141 (36) minutes, average (SD) estimated blood loss was 114 (48) milliliters. Mean follow-up time was 40.9 (17.7) months. Postoperatively, mean (SD) BMI was 28.1 (5.9). The number of patients in prolapse stages were: apical stage 0-I: 13, apical II-III: 0; anterior 0-I: 10, anterior II-III: 2; posterior 0-I: 13, posterior II-III: 0. All stages were statistically significantly improved from preoperative staging. Postoperatively, 2 patients had a stage II cystocele, but both were asymptomatic. One patient had anterior wall mesh erosion, which was treated successfully with estrogen cream. Three patients had attempted pregnancy. At the time of follow-up, one patient had carried to term, and delivered via uncomplicated cesarean section. Another was 12 weeks pregnant. The last was attempting to get pregnant, although HSG demonstrated lack of dye spillage from a fallopian tube. Average (SD) PISQ-12, PFDI-20, and IIQ-7 scores were 37.6 (4.7), 38.6 (43.9), and 1.1 (2.5), respectively. CONCLUSION: Our study presents optimistic anatomic and symptomatic results from ASH. At an average of 40.9 months postoperatively, none of the thirteen patients had required further evaluation for prolapse or incontinence. Two of three patients who desired childbearing were able to achieve pregnancy, and one delivered via uncomplicated cesarean section. All quality of life post-operative scores indicated a high quality of life. OBJECTIVES: The goal of this study is to examine if a phone call reminder would influence the rate of missed appointment ("noshows") at an urogynecology clinic. MATERIALS AND METHODS: This is an observational study, which took place between May 2015 and August 2016 at an academic medical center. Two cohorts of subjects, who were scheduled for an urodynamic testing, were analyzed and compared. Group 1 (n ¼ 42) received a phone call reminder a day before the scheduled procedure (between February 3, 2016 and August 5, 2016) and Group 2 (n ¼ 49) did not (between May 6, 2015 and January 27, 2016). The EPIC database was utilized. The demographic data including age, ethnicity, marital status, type of insurance, occupation, medical co-morbidities, travel time to clinic and wintertime (December to February). The statistical analysis was done using SAS 9.3. The prevalence of no-show rate was calculated. The continuous variables were analyzed using student's t-test and categorical variables were analyzed using chi-square and Fisher's exact test. Any p value < 0.05 was considered statistically significant. RESULTS: Demographics in both groups did not show any differences (see Table 1 ). A telephone call reminder did not influence the "noshow" rate in our clinic population (Group 1:16.67%, and Group 2: 18.37% , p ¼ 0.83). Wintertime for the scheduled procedure was found to be an influencing factor for the no-show with statistical significance (p ¼ 0.02, see Table 2 ). The other factors did not show any differences. CONCLUSION: Missed appointment represents significant loss of resources. Data from this study show that the "no-show" rate in our Urogynecology clinic is 16-18%, which is comparable to previously reported rate in other discipline outpatient clinics. A telephone call reminder did not improve the "no-show" rate in our study. A factor that influenced the "no-show" rate was found to be the wintertime. Future analysis as well as additional new intervention strategies may help in the better administration of outpatient clinics.
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